Open AccessAtypical facial onset Guillain-Barré syndrome following first dose of COVISHIELD vaccine
Author(s) -
RangenahalliVasudev Aravinda,
AUTHOR_ID,
Priyanka Tater,
Harsha A. Huliyappa,
Christy Joseph Manual,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2021
Publication title -
romanian journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.111
H-Index - 4
eISSN - 2069-6094
pISSN - 1843-8148
DOI - 10.37897/rjn.2021.3.19
Subject(s) - guillain barre syndrome , medicine , covid-19 , pediatrics , pandemic , immunization , respiratory distress , acute respiratory distress , intensive care medicine , immunology , surgery , virology , disease , antibody , lung , outbreak , infectious disease (medical specialty)
In the midst of the global pandemic of COVID-19 and its significant morbidity and mortality reported across the world due to severe acute respiratory distress syndrome (SARS), it has always been posing a new set of complications each passing day. As we are still in the process of understanding about the complications related to COVID-19, we are encountered with complications related to immunization for COVID-19. We are reporting a case of facial onset Guillain-Barré syndrome (GBS) in the patient who received first dose of COVISHIELD vaccine a couple of weeks prior to the onset of his illness.